ASPARTYL-TRNA SYNTHETASES
    6.
    发明申请

    公开(公告)号:US20140302075A1

    公开(公告)日:2014-10-09

    申请号:US14360576

    申请日:2012-12-06

    CPC classification number: C12N9/93 A61K38/00 C07K2319/40 Y02A50/411

    Abstract: The present invention provides aspartyl-tRNA synthetase derived proteins (DRS polypeptides) with altered cysteine content, compositions comprising the same, and methods of using such polypeptides and compositions for treating or diagnosing a variety of conditions. The DRS polypeptides of the invention have immunomodulatory properties, and exhibit improved activity and stability.

    Abstract translation: 本发明提供具有改变的半胱氨酸含量的天冬氨酰-tRNA合成酶衍生蛋白(DRS多肽),包含其的组合物,以及使用这些多肽和组合物治疗或诊断各种病症的方法。 本发明的DRS多肽具有免疫调节特性,并表现出改进的活性和稳定性。

Patent Agency Ranking